Chardan Healthcare Acquisition 2 Corp (CHAQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CHAQ | AMGN | REGN | VRTX | GSK |
| Company | Chardan Healthcare Acquisition 2 Corp | Amgen Inc | Regeneron Pharmaceuticals | Vertex Pharmaceutic | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 9.35 | 306.42 | 984.04 | 451.90 | 45.42 |
| High | 9.35 | 307.50 | 995.41 | 457.66 | 45.45 |
| Low | 8.06 | 303.90 | 983.16 | 449.42 | 45.03 |
| Last | 8.41 | 305.84 | 985.02 | 456.95 | 45.12 |
| Change | -0.95 | -0.66 | +4.45 | +6.15 | -0.03 |
| % Change | -10.15% | -0.22% | +0.45% | +1.36% | -0.07% |
| Volume | 242,600 | 2,422,285 | 255,415 | 1,044,673 | 2,209,546 |
| 20-Day Average Volume | 87,520 | 2,868,694 | 424,856 | 1,162,004 | 3,931,446 |
| Previous Close | 9.36 | 306.50 | 980.57 | 450.80 | 45.15 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 9.87 | 303.24 | 961.40 | 424.54 | 44.27 |
| 20-Day Raw Stochastic | 14.23% | 68.74% | 88.79% | 98.92% | 82.13% |
| 20-Day Relative Strength | 17.92% | 57.73% | 59.92% | 74.37% | 62.21% |
| Weighted Alpha | -24.94 | +36.96 | +35.05 | +40.81 | +35.22 |
| Today's Opinion | 100% Sell | 88% Buy | 88% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 88% Buy | 88% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 40% Sell | 72% Sell | 8% Buy | 8% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -16.07% since 08/26/21 | -2.12% since 05/17/24 | +0.28% since 05/17/24 | +2.64% since 05/17/24 | +0.31% since 05/17/24 |
| Low | 8.06 on 09/02/21 | 303.90 on 05/24/24 | 975.73 on 05/23/24 | 437.46 on 05/21/24 | 44.40 on 05/20/24 |
| High | 10.52 on 08/30/21 | 316.67 on 05/21/24 | 997.87 on 05/22/24 | 457.66 on 05/24/24 | 45.79 on 05/22/24 |
| 1-Month | |||||
| %Chg | -16.65% since 08/02/21 | +12.03% since 04/24/24 | +8.66% since 04/24/24 | +14.02% since 04/24/24 | +10.43% since 04/24/24 |
| Low | 8.06 on 09/02/21 | 265.72 on 04/26/24 | 875.22 on 04/26/24 | 391.70 on 04/30/24 | 40.81 on 04/25/24 |
| High | 10.52 on 08/30/21 | 322.60 on 05/03/24 | 997.87 on 05/22/24 | 457.66 on 05/24/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | -16.36% since 06/02/21 | +5.76% since 02/23/24 | +0.39% since 02/23/24 | +6.24% since 02/23/24 | +6.87% since 02/23/24 |
| Low | 8.06 on 09/02/21 | 260.68 on 04/19/24 | 875.22 on 04/26/24 | 391.01 on 04/18/24 | 39.15 on 04/18/24 |
| High | 10.52 on 08/30/21 | 322.60 on 05/03/24 | 998.33 on 02/28/24 | 457.66 on 05/24/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | -17.39% since 03/02/21 | +15.21% since 11/24/23 | +23.39% since 11/24/23 | +29.43% since 11/24/23 | +26.00% since 11/24/23 |
| Low | 8.06 on 09/02/21 | 260.68 on 04/19/24 | 792.57 on 11/28/23 | 346.29 on 11/28/23 | 35.35 on 11/29/23 |
| High | 10.52 on 08/30/21 | 329.72 on 02/05/24 | 998.33 on 02/28/24 | 457.66 on 05/24/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 90,643 | 164,417,328 | 108,045,080 | 116,330,288 | 93,570,672 |
| Shares Outstanding, K | 10,778 | 536,435 | 110,186 | 258,053 | 2,072,440 |
| Annual Sales | 0 | 28,190,000,000 | 13,117,200,000 | 9,869,200,000 | 37,725,000,000 |
| Annual Net Income | -780,000 | 6,717,000,000 | 3,953,600,000 | 3,619,600,000 | 6,129,940,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 3,145,000,000 | 2,690,600,000 | 9,337,020,000 |
| Last Quarter Net Income | -490,000 | -113,000,000 | 722,000,000 | 1,099,600,000 | 1,326,430,000 |
| 60-Month Beta | 0.05 | 0.60 | 0.17 | 0.39 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | 9.55 on 05/02/24 | 4.76 on 05/06/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | N/A | 05/02/24 | 05/02/24 | 05/06/24 | 05/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.61 | 26.51 | 29.72 | 11.33 |